Vitamin D   Wird in der Haut unter Einwirkung von UV-Licht aus seinen Vorstufen gebildet. Hohe Vitamin D-Spiegel sollen das Risiko vermindern, an MS zu erkranken, ob es auch die Krankheitsaktivität einer bestehenden MS vermindern kann, wird kontrovers diskutiert. Ein Fläschen Oleovit D3 kostet in der Apotheke übrigens weniger als 3 Euro. Anm. des Autors dieser Homepage: Ich führe tgl. 10 - 20 Tropfen Oleovit D3 zu und kontrolliere vierteljählich meinen Vit. D- Spiegel. Besprechen Sie Ihr Vorgehen mit Ihrem Arzt. Vit D auf den Haaransatz getropft soll übrigens das Haarwachstum fördern - http://www.zentrum-der-gesundheit.de/duennes- haar.html.   5. 1. 2010 (aktualisiert); amsel.de; Vitamin D und MS-Symptome? Das flüchtige Prohormon reduziert möglicherweise die Schubrate deutlich, so australische Forscher. Ein schottisches Team sieht ein erhöhtes MS-Risiko bei Aprilgeborenen. http://www.amsel.de/multiple-sklerose-news/medizin/index.php?kategorie=medizin&anr=3451 „Nun hat eine Studie mit rund 150 Personen in Tasmanien (einer Insel südöstliche von Australien) ergeben, dass der Vitamin- D-Spiegel und MS-Symptome in Zusammenhang stehen könnten.“   12. 1. 2010; Leben mit MS; Vitamin D könnte MS-Symptome lindern; http://www.leben-mit-ms.de/news/aktuell/vitamin-d-koennte-ms-symptome-lindern/246534/1/   11. 2. 2010; pressetext.at; Sonnenbaden macht Männer scharf, Vitamin-D hebt Testosteronspiegel deutlich an;http://www.pressetext.at/news/100211026/sonnenbaden-macht-maenner-scharf/   9. 4. 2010; DWSG; Vitamin D und Multiple Sklerose: Gibt es einen Zusammenhang? http://www.dmsg.de/multiple-sklerose-news/index.php?w3pid=news&kategorie=forschung&anr=2129   28. 4. 2010; Neurology;  A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis http://www.neurology.org/cgi/content/abstract/74/23/1852 „Conclusions: High-dose vitamin D (10,000 IU/day) in multiple sclerosis is safe, with evidence of immunomodulatory effects.“   Jun. 2010; PubMed.gov; Vitamin D and multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/20494325   20. 5. 2010; Aktiv mit MS; UV-Licht oder Vitamin D – was lindert die Symptome der Multiplen Sklerose? http://www.aktiv-mit-ms.de/0-219-news.html   June 2010; The Lancet Neurology, Volume 9, Issue 6, Pages 599 – 612; Vitamin D and multiple sclerosis http://www.thelancet.com/journals/lancet/article/PIIS1474-4422(10)70086-7/abstract   1. 6. 2010; amsel.de; Sonnenbad statt Vitamin D? http://www.amsel.de/multiple-sklerose-news/index.php?kategorie=medizin&cnr=32&anr=3647   29. 6. 2010; aerzteblatt.de; Vitamin D beeinflusst die geistige Aktivität http://www.aerzteblatt.de/nachrichten/41781/Vitamin_D_beeinflusst_die_geistige_Aktivitaet.htm   29. 6. 2010; Leben mit MS; Vitamin D beeinflusst die Schubrate bei Kindern mit Multipler Sklerose http://www.leben-mit-ms.de/news/aktuell/vitamin-d-beeinflusst-die-schubrate-bei-kindern-mit-multipler-sklerose/252311/1/   8. 6. 2010; Aktiv mit MS; Sonnenscheue Mütter könnten das Multiple-Sklerose-Risiko ihrer Babys erhöhen http://www.aktiv-mit-ms.de/0-222-news.html   6. 7. 2010; AerzteZeitung.de; Mehr Sonne, seltener MS? http://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/multiple_sklerose/default.aspx?sid=610501   30. 9. 2010; Leben mit MS; Neue Hinweise auf die Bedeutung von Vitamin D http://www.leben-mit-ms.de/news/aktuell/neue-hinweise-auf-die-bedeutung-von-vitamin-d/254849/   19. 10. 2010; Leben mit MS; Vitamin D könnte vor Krankheitsschüben schützen http://www.leben-mit-ms.de/news/aktuell/vitamin-d-koennte-vor-krankheitsschueben-schuetzen/255793/   2. 11. 2010; PubMed.gov; The emerging role of vitamin D binding protein in multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/21042807 „Several recent studies show that DBP (Vitamin D binding protein) levels in the cerebrospinal fluid correlate with MS course, being lower during relapses and higher in the secondary progressive phase. Further studies are needed to elucidate the potential use of DBP as a biological marker of MS course, but may be of use given the current lack of diagnostic tools for the prediction of MS development and progression.“   3. 11. 2010; PubMed.gov; Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. http://www.ncbi.nlm.nih.gov/pubmed/21047880 „Conclusions Vitamin D metabolites have protective associations with disability and brain atrophy in MS. In particular, the results indicate strong associations for the 24, 25(OH)(2)VD(3) metabolite, which has not been extensively investigated in MS patients.“   3. 11 2010; Leben mit MS; Wissenschaftler setzt sich für umfassende Untersuchungen zu Vitamin D ein http://www.leben-mit-ms.de/news/aktuell/wissenschaftler-setzt-sich-fuer-umfassende-untersuchungen-zu-vitamin-d-ein/255804/   10. 11. 2010; amsel.de; Raus mit uns an die frische Luft! http://www.amsel.de/multiple-sklerose-news/medizin/index.php?kategorie=medizin&anr=3792   26. 11. 2010; Leben mit MS; Vitamin D-Schutzeffekt bei Frauen stärker ausgeprägt als bei Männern http://www.leben-mit-ms.de/news/aktuell/vitamin-d-schutzeffekt-bei-frauen-staerker-ausgepraegt-als-bei-maennern/255822/   1. 12. 2010; aerzteblatt.de; USA: Vitamin D- und Kalzium-Supplemente meist unnötig http://www.aerzteblatt.de/nachrichten/43722/USA_Vitamin_D-_und_Kalzium-Supplemente_meist_unnoetig.htm   1. 12. 12010; e-med forum; Klinik und MRT-Befunde der MS hängen mit Vitamin-D-Metaboliten zusammen http://www.emed-ms.de/index.php?id=533&tt_news=1517   8. 12. 2010; PubMed.gov; Vitamin D for the management of multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/21154396 „The trial provided some evidence of the potential benefit of the intervention on several outcomes i.e. the annualised relapse rate; EDSS scores; suppression of T-cell proliferation and illustrated a measure of comparative safety in the relative absence of any adverse events or of high serum calcium levels over the study period.“   13. 12. 3010; PubMed.gov; Safety and T Cell Modulating Effects of High Dose Vitamin D(3) Supplementation in Multiple Sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/21179201   16. 12. 2010; PubMed.gov; Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/21160231 „Conclusions: The current study provides evidence for an association between vitamin-D-related exposures during childhood and early adolescence and the timing of MS symptom onset, and supports vitamin D as a potential modulator of the clinical course of this disease.   6. 1. 2011; PubMed.gov; Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/21212086 „Conclusions: Vitamin D status may be differentially associated with antibody levels to common childhood viruses among seropositive subjects.“   10. 1. 2011; Pressemitteilungen-online.de; Vitamin D-Mangel - 15 Minuten in der Mittagssonne empfohlen http://www.pressemitteilungen-online.de/index.php/vitamin-d-mangel-15-minuten-in-der-mittagssonne-empfohlen/   Feb. 2011; PubMed.gov; Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. http://www.ncbi.nlm.nih.gov/pubmed/21047880   Apr. 2011; PubMed.gov; Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. http://www.ncbi.nlm.nih.gov/pubmed/21186064 18. 6. 2011; Neurology; Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis http://www.neurology.org/content/79/3/261.abstract?sid=de415849-1503-4e1d-b0c9-a0521f5d8747 „Conclusions: Our finding that higher vitamin D levels are associated with decreased exacerbation risk in relapsing-remitting MS suggests a beneficial effect of vitamin D on disease course in MS. However, the possibility of reverse causality cannot be ruled out completely. Randomized intervention studies are therefore needed to investigate the effect of vitamin D supplementation in MS.“ 10. 11. 2010; MS-Gateway; Klinik und MRT-Befunde der MS hängen mit Vitamin-D-Metaboliten zusammen www.ms-gateway.de/scripts/pages/1366.php   1. 9. 2011; PubMed.gov; Vitamin D in the elderly: 5 points to remember. http://www.ncbi.nlm.nih.gov/pubmed/21896429 „A daily intake of at least 800-1,000 IU supplemental vitamin D(3) per day is the key.“   19. 9. 2011; e-med forum: Gene, Entzündungen und die Rolle des Vitamin D bei MS http://www.emed-ms.de/index.php?id=533&tt_news=1704http://www.emed   10. 10. 2011; PubMed.gov; Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/21992813 „CONCLUSIONS: We documented no correlation between vitamin D levels and decreased BMD (bone mineral density) at femoral neck and lumbar spine in RRMS (relapsing-remitting MS) patients. Vitamin D insufficiency appears not to be the underlying cause of secondary osteoporosis in MS.“   19. 10. 2011; Leben mit MS; So schützt Vitamin D vor MS http://www.leben-mit-ms.de/de/patientenundangehoerige/nachrichten/archiv/so_schuetzt_vitamin_d_vor_ms- 006838406.html?mode=detail&newsid=1319006838406&vcid=006838406&backUrl=patientenundangehoerige/nachrichten/arc hiv/nachrichten-812.html?mode=archiv+9 25. 10. 2011; Neurology; A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis http://www.neurology.org/content/77/17/1611.abstract?sid=ac04379c-792a-449f-bd64-8d2d6733fe8f „Conclusion: We did not find a therapeutic advantage in RRMS for high-dose D2 over low-dose D2 supplementation.“   30. 1. 2012; amsel.de; Wirkung einer Vitamin D-Gabe nur bei bestimmten Personengruppen und Patienten gesichert http://www.emed-ms.de/index.php?id=533&tt_news=1789   21. 2. 2011: PubMed.gov; Effect of vitamin D3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. http://www.ncbi.nlm.nih.gov/pubmed/22354743 "Conclusion: Supplementation with 20,000 IU vitamin D(3) weekly did not result in beneficial effects on the measured multiple sclerosis-related outcomes. This study was not powered to address clinical outcomes, but none of the results were suggestive of an effect in this unselected population of fully ambulatory persons with multiple sclerosis."   6. 3. 2012; Aktiv mit MS; Bewusster Umgang mit Vitamin D bei Multipler Sklerose gefordert http://www.aktiv-mit-ms.de/aktiv-leben/ms-ticker/ms-meldungen/ernaehrung-und-ms-bewusster-umgang-mit-vitamin-d-bei- multipler-sklerose-gefordert-1/   10. 4. 2012; PubMed.gov; Vitamin D for prevention of diseases? http://www.ncbi.nlm.nih.gov/pubmed/22492477 " Even a controlled supplementation of vitamin D in patients with vitamin D deficiency is considered as reasonable. However, an uncritical substitution of high-dose vitamin D should be avoided because of the risk of hypercalcaemia." 6. 8. 2012; Aktiv mit MS; Hoher Vitamin D-Spiegel reduziert MS-Risiko bei klinisch isoliertem Syndrom http://www.aktiv-mit-ms.de/aktiv-leben/ms-ticker/ms-meldungen/kongressbericht-hoher-vitamin-d-spiegel-reduziert-ms-risiko- bei-klinisch-isoliertem-syndrom/ 23. 8. 2012; MSJ; Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial http://msj.sagepub.com/content/18/8/1144.abstract „Conclusion: Supplementation with 20,000 IU vitamin D3 weekly did not result in beneficial effects on the measured multiple sclerosis-related outcomes. This study was not powered to address clinical outcomes, but none of the results were suggestive of an effect in this unselected population of fully ambulatory persons with multiple sclerosis.“ Aug. 2012; PubMed.gov; Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/22926855 „INTERPRETATION: Vitamin D levels are inversely associated with MS activity on brain MRI. These results provide further support for a randomized trial of vitamin D supplementation. ANN NEUROL 2012;72:234-240.“ 30. 8. 2012; Leben mit MS; Hoher Vitamin-D-Spiegel reduziert das Risiko für das Entstehen einer Multiplen Sklerose http://www.leben-mit-ms.de/de/patientenundangehoerige/nachrichten/hoher_vitamin-d- spiegel_reduziert_das_risiko_f%C3%BCr_das_entstehen_einer_multiplen_sklerose- 310484965.html?mode=detail&newsid=1346310484965&vcid=310484965&backUrl=patientenundangehoerige/nachrichten/nac hrichten-216.html 6. 11. 2012; aerzteblatt.de; Länger leben mit weniger Vitamin D? http://www.aerzteblatt.de/blog/52302 27. 11. 2012; PunMed.gov; Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/23186958 „Conclusion: Vitamin D deficiency in MS patients should be avoided. In addition, the risk of developing MS might be reduced by maintaining optimal vitamin D levels in the healthy population. Larger randomized interventional trials are needed to clarify the therapeutic effect of vitamin D in MS.“ 14. 12. 2012; PubMed.gov; Vitamin D in Systemic and Organ-Specific Autoimmune Diseases. http://www.ncbi.nlm.nih.gov/pubmed/23238772 „In addition, we discuss the correlations between vitamin D levels and clinical manifestations and/or activity of diseases. In this context, we address the rational for vitamin D supplementation in patients suffering from autoimmune diseases.“ (Anm. des Autors dieser Homepage: Z.b. mit OLEOVIT D3-Tropfen, die kosten in der Apotheke etwa 2 €. Besprechen Sie es mit ihrem Arzt.) 27. 12. 2012; Ärzte Zeitung; Weniger Infekte mit Vitamin D http://www.aerztezeitung.de/medizin/krankheiten/infektionskrankheiten/erkaeltungskrankheiten/default.aspx?sid=829063&cm_ mmc=Newsletter-_-Newsletter-C-_-20121227-_-Erk%C3%A4ltungs-Krankheiten 2012; PubMed.gov; Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. http://www.ncbi.nlm.nih.gov/pubmed/23278659 „CONCLUSION:  We recommend that MS patients are supplemented with 800 IU of vitamin D at least from autumn to spring. Alternatively, 25-hydroxyvitamin D should be measured and the nadir level estimated and supplementation given to a target level between approximately 75 and 125 nm.“ Nov. 2000; PubMed.gov; Vitamin D: a natural inhibitor of multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/11115787 2011; PubMed.gov; Therapeutic effect of vitamin D3 in multiple sclerosis patients. http://www.ncbi.nlm.nih.gov/pubmed/21542721 „Our results showed no significant difference between the treatment and the control groups in the expanded disability status scale scores and number of gadolinium-enhancing lesions during the 6-month treatment period. After 6 months, the levels of cell proliferation in the vitamin D treatment group were significantly lower than the control group. Also, the levels of transforming growth factor-beta and interleukin-10 in the vitamin D treatment group were significantly higher than the control group. This result suggests that vitamin D therapy may help prevent the development of MS and could be a useful addition to the therapy.“ 22. 1. 2013; PubMed.gov; Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression. http://www.ncbi.nlm.nih.gov/pubmed/23339019 „In conclusion, here we observed upregulated DBP (Vitamin D-binding protein) in the cerebrospinal fluid could serve as a specific diagnostic biomarker for the progression of multiple sclerosis. Next, we demonstrate the vital function of increased levels of free vitamin D metabolites for multiple sclerosis treatment. Finally, vitamin D supplements may be particularly beneficial for SPMS patients.“ Feb. 2013; PubMed.gov; [Vitamin D and multiple sclerosis]. http://www.ncbi.nlm.nih.gov/pubmed/23400652 „CONCLUSIONS. Observation-based studies have shown a consistent inverse relationship between concentrations of vitamin D and the risk of MS. The intervention studies (basically randomised double-blind placebo-controlled trials), however, offer data that are not conclusive. The current context opens up the possibility of conducting prospective and intervention-based studies in the future that will settle the nature of this association in a more convincing manner.“ 19. 2. 2013; PubMed.gov; Vitamin D as a clinical biomarker in multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/23480560 „Expert opinion: Mounting evidence from epidemiology, genetic, retrospective clinical studies and emerging basic science studies support a strong rationale for how vitamin D could be an important modifier of MS disease. Well-designed clinical trials are now ongoing and will provide further insight on how vitamin D supplementation may impact MS.“ Mar. 2013; PubMed.gov; Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/23483715 „While awaiting these incontrovertible results, which might be long in coming, patients with MS who are currently in vitamin D insufficiency should be supplemented, at least for their general health status, using moderate doses of the vitamin.“ 22. 5. 2013; PubMed.gov; The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. http://www.ncbi.nlm.nih.gov/pubmed/23698130 „We found no significant association between high-dose vitamin D treatment and risk of MS relapse. In conclusion, although no significant association between high-dose vitamin D treatment and risk of MS relapses was found, the studies were limited by several methodological limitations. Further larger, more prolonged studies are merited.“ 30. 5. 2013; PubMed.gov; Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives. http://www.ncbi.nlm.nih.gov/pubmed/23737310 "Compared to the healthy subject, serum levels of vitamin D were significantly lower in patients with MS. This difference was only significant in women. Observed difference of vitamin D levels of both groups were significant in summer. This study continues to support the role of vitamin D deficiency in MS." 13. 6. 2013; PubMed.gov; Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/23763464 „CONCLUSION: We found that higher levels reported sun exposure, rather than 25(OH)D levels, were associated with less depressive symptoms and levels of fatigue. The role of UV or light therapy will need to be evaluated in randomized controlled trials to confirm an effect on these symptoms in MS.“ Mai 2013; PubMed.gov; Vitamin d3 concentration correlates with the severity of multiple sclerosis. http://www.ncbi.nlm.nih.gov/pubmed/23930170 „CONCLUSIONS: Our findings not only further disclose the lower level of vitamin D in MS patients in comparison with healthy controls, but also support the association between vitamin D and disease severity in MS.“ 17. 9. 2013; Aktiv mit MS; Niedrige Vitamin-D-Spiegel erhöhen MS-Risiko http://www.aktiv-mit-ms.de/ms-news/ms-ticker/detail/artikel/niedrige-vitamin-d-spiegel-erhoehen-ms-risiko/ 2013; Iran J. of Neurology; Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis? http://www.ncbi.nlm.nih.gov/pubmed/24250900 „CONCLUSION: Our findings did not suggest a protective association for serum vitamin D levels against disability in MS patients.“ 27. 11 2013; eifelzeitung.de; Pilze sind die Vitamin D-Lieferanten in der dunklen Jahreszeit http://www.eifelzeitung.de/2013/11/pilze-sind-vitamin-d-lieferanten-in-dunklen-jahreszeit-47626/ Anm.: oder Olerovit D3 (Kostet in der Apotheke etwa 2 €) ... 10. 12. 2013; NetDoktot.de; Vitamin D: Wie das Sonnenvitamin Multiple Sklerose stoppt http://www.netdoktor.de/News/Vitamin-D-Wie-das-Sonnenvit- 1138101.html?utm_source=Newsletter+11.12.2013&utm_medium=E-Mail&utm_term=Vitamin-D-Wie-das-Sonnenvitamin- Multiple-Sklerose-stoppt&utm_content=1 30. 9. 2013; PubMed.gov; [The impact of the vitamin D in neurological diseases and neurorehabilitation: from demencia to multiple sclerosis. Part I: the role of the vitamin D in the prevetion and treatment of multiple sclerosis]. http://www.ncbi.nlm.nih.gov/pubmed/24358684 „There is no consensus for the role of vitamin D in multiple sclerosis yet, but until the achieving this, the diagnosis and the treatment of the vitamin D deficiency is crucial for scelrosis multiplex patients and in cases of elevated risk. Data shows, that in patient with multiple sclerosis the normal vitamin D level is suboptimal, however the exact role of vitamin D and doses must be clarified by interventional studies.“ 17. 9. 2013; Multiple Sclerosis Didcovery forum; Single Calcitriol Dose Beats Back EAE in Mice - Vitamin D zaps inflammatory T cells in the CNS and leads to sustained remission http://www.msdiscovery.org/news/new_findings/7593-single-calcitriol-dose-beats-back-eae-mice „Just a single dose of calcitriol - he active form of vitamin D—reversed paralysis in mice with an experimental form of multiple sclerosis, a new study finds. Once established, the relapse could be maintained through dietary supplementation with the vitamin.“ Anm.: Calcitrol ist ethalten in Rohaltrol®, wird gegeben beim sek. Hyperparathyreoidismus, ist indikationspflichtig, bedarf regelmäßiger Kontrollen des Ca-Spiegels. 10. 1. 2014; DMSG; Kann Vitamin D die Multiple Sklerose bremsen? http://www.dmsg.de/multiple-sklerose-news/index.php?w3pid=news&kategorie=forschung&anr=4957 17. 1. 2014; ÄrzteZeitung; Bei erstem MS-Schub - Wenig Vitamin D, schlechte Prognose http://www.aerztezeitung.de/medizin/krankheiten/neuro- psychiatrische_krankheiten/multiple_sklerose/default.aspx?sid=852803&cm_mmc=Newsletter-_-Newsletter-C-_-20140117-_- Multiple+Sklerose 20. 1. 2014; PubMed.gov; Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression. http://www.ncbi.nlm.nih.gov/pubmed/24445558 21. 1. 2014; aerzteblatt.de; Multiple Sklerose: Vitamin D könnte Krankheitsverlauf verlangsamen http://www.aerzteblatt.de/nachrichten/57282 23. 1. 2014; pressetext.com; Vitamin D kann Multiple Sklerose abwehren - Studie sieht Substanz als wichtigen Risikofaktor für Krankheitsverlauf http://www.pressetext.com/news/20140123001 24. 1. 2014; aerzteblatt.de; Vitamin D-Supplemente: Meta-Analyse sieht keinen Zusatznutzen http://www.aerzteblatt.de/nachrichten/57336 31. 1. 2014; pressetext.com; Nichts für Athleten: Vitamin D2 schadet Muskeln http://www.pressetext.com/news/20140131003 Feb. 2014; PubMed.gov; Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: Consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology. http://www.ncbi.nlm.nih.gov/pubmed/24604370 „There is no scientific evidence up to the production of this consensus for the use of vitamin D as monotherapy for MS in clinical practice.“ 20. 3. 2014; Aktiv mit MS; Einfluss von Vitamin-D-Status auf MS https://www.aktiv-mit-ms.de/ms-news/ms-ticker/detail/artikel/einfluss-von-vitamin-d-status-auf-ms/ “Ich bin der Herr im Haus, was maine Frau sagt, wird gemacht.” Heinz Rühmann Zur Medikamenten-Übersicht http://georgieff.at/